Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 21, 2025 04:37 ET | Source: Research and Markets

Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer Market Research Report 2025: Next-Gen TKIs and Immunotherapy Show Promise for EGFR Lung Cancer

Dublin, Oct. 21, 2025 (GLOBE NEWSWIRE) -- The "Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer Market - A Global and Regional Analysis: Focus on Drug Class, Therapy Type, and Region -...
September 03, 2025 04:15 ET | Source: Research and Markets

Erlotinib Generics Market Trends and Business Opportunities 2025-2030 - Shift from Branded Erlotinib to Generics Boosts Competition, Access, and Pricing Strategies

Dublin, Sept. 03, 2025 (GLOBE NEWSWIRE) -- The "Erlotinib Generics Market by Application (Non Small Cell Lung Cancer, Pancreatic Cancer), Formulation (Tablet Strength), Distribution Channel, End...
February 18, 2025 09:22 ET | Source: Research and Markets

Pancreatic Cancer Pipeline Analysis Report Featuring Key Players - Pfizer, Sanofi, Novartis Pharmaceuticals, Bristol-Myers Squibb, Eisai, AstraZeneca, GlaxoSmithKline, F-Hoffmann-La Roche

Dublin, Feb. 18, 2025 (GLOBE NEWSWIRE) -- The "Pancreatic Cancer Pipeline Analysis Report" report has been added to ResearchAndMarkets.com's offering.The pancreatic cancer drug pipeline analysis...
March 07, 2024 04:09 ET | Source: Research and Markets

Pancreatic Cancer Drugs Global Market Report 2024

Dublin, March 07, 2024 (GLOBE NEWSWIRE) -- The "Pancreatic Cancer Drugs Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The pancreatic cancer drugs market size...
April 14, 2022 06:38 ET | Source: Research and Markets

$3.4+ Billion Worldwide Pancreatic Cancer Drugs Industry to 2031 - Identify Growth Segments for Investment

Dublin, April 14, 2022 (GLOBE NEWSWIRE) -- The "Pancreatic Cancer Drugs Global Market Report 2022, Type, End User, Drugs" report has been added to ResearchAndMarkets.com's offering. This report...